Anthropic AI protein design success drives TWST surge

 

• Anthropic Aug 18 blog details Claude AI designing novel binders for 14/15 targets
• Twist Bioscience synthesized and wet-lab tested the AI-generated proteins
• Achieved 22-35% binding success rates vs typical 10-15% benchmarks
• Validates Twist's growing role in AI-driven drug discovery and synthesis
• Builds on early Aug Q3 earnings beat, raised guidance, and $300M offering
• X chatter and call buying amplified momentum from recent highs

https://finviz.com/stock?t=TWST&p=d